Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEMV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,858
Award facts
- Contract value 100% obligated
- $37,858.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,858.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL syringes. This firm fixed-price delivery order, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The IDC enables the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare systems. This award of Nucala, a pharmaceutical injection used in respiratory treatments, reflects the company's consistent portfolio of specialty pharmaceutical deliveries to the Defense Logistics Agency, which has included oncology treatments, biologics, auto-injectors, and other specialized medications to support the medical needs of Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FKEMV?
SPE2DB25FKEMV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FKEMV worth?
The government has obligated $37,858 on SPE2DB25FKEMV.
Is contract SPE2DB25FKEMV an order under another contract?
Yes. SPE2DB25FKEMV is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMV competed?
The extent of competition for SPE2DB25FKEMV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award